October 9, 2025Circulation Research

Abstract Wed033: Characterization of iPSC lines from dilated cardiomyopathy patients carrying a mutation in the RBM20 gene

View Full Paper

Ask AI

Bookmark

The study successfully established induced-pluripotent stem cell lines from dilated cardiomyopathy patients with RBM20 mutations.
Using RT-qPCR and immunofluorescence, pluripotency markers SOX2, NANOG, and OCT3/4 were confirmed in iPSCs after one week.
Karyotyping analysis showed no chromosomal abnormalities in iPSC lines, indicating their potential as a reliable model for studying DCM.
The findings highlight the utility of these patient-derived iPSCs in understanding the pathophysiology of dilated cardiomyopathy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Research reports successful generation of iPSCs carrying RBM20 mutations in patients with dilated cardiomyopathy, suggesting a model for disease study.

Cite This Study

Rajasekaran et al. (2025) studied this question.

synapsesocial.com/papers/68e80eb363e2e2f707877dba https://doi.org/10.1161/res.137.suppl_1.wed033

View Full Paper

Ask AI

Bookmark

Implication

Research reports successful generation of iPSCs carrying RBM20 mutations in patients with dilated cardiomyopathy, suggesting a model for disease study.

Abstract Wed033: Characterization of iPSC lines from dilated cardiomyopathy patients carrying a mutation in the RBM20 gene

Key Points

Discussion

Implication

Cite This Study

Abstract Wed033: Characterization of iPSC lines from dilated cardiomyopathy patients carrying a mutation in the RBM20 gene

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider